European Investment Bank

Orano is a leading global company based in Courbevoie, France, specializing in nuclear power and renewable energy solutions. The company offers a comprehensive range of services covering every stage of the nuclear fuel cycle, including reactor design, construction, and operational support. With a strong emphasis on safety and advanced technology, Orano is committed to supplying low-carbon power generation solutions. Additionally, it engages in renewable energy initiatives through partnerships aimed at developing high-tech solutions. As energy demand increases and the need for sustainable practices intensifies, Orano focuses on creating cleaner energy alternatives that contribute to reducing greenhouse gas emissions. The company aims to enhance transparency, coherence, and efficiency in its operations while preparing for the future energy landscape.

Universal Diagnostics, S.L. is a biomedicine company based in Seville, Spain, with an additional office in San Francisco, California. Founded in 2012, the company specializes in developing blood-based diagnostic tests aimed at the early detection of various cancers, including colorectal, lung, breast, liver, pancreatic, and gastric cancers. Its innovative platform utilizes proprietary methylation marker panels, allowing for the analysis of a simple blood sample to identify individuals at risk and facilitate timely medical intervention. The company's flagship assay focuses on colorectal cancer screening, which is critical given the late-stage detection challenges that significantly reduce survival rates. Universal Diagnostics collaborates with international research institutions, hospitals, and biobanks to advance its research and development efforts, striving to transform cancer detection into a more accessible and effective process.

Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Royal Schiphol Group N.V. is the owner and operator of Amsterdam Airport Schiphol, the national airport of the Netherlands, as well as other airports including Rotterdam The Hague Airport and Lelystad Airport. The company manages and develops airport operations, providing essential services and facilities to airlines, travelers, handling agents, and logistics providers. It also grants concessions for various shops, restaurants, and entertainment options within the airport, while operating its own retail spaces and car parks. Additionally, Royal Schiphol Group develops and manages properties related to airport activities, offering various locations and rental agreements for businesses and logistics service providers. Established in 1958 and headquartered in Schiphol, the company plays a crucial role in aviation and transportation in the Netherlands and beyond.

Samotics is a Dutch technology company that specializes in improving the availability of industrial electric motors and rotating equipment through its AI-powered condition monitoring platform. The company leverages data from sensors and operational systems to identify early warnings of abnormal behavior, enabling targeted inspections and predictive maintenance. By analyzing this data, Samotics helps global industrial companies reduce energy waste and unplanned downtime, ultimately lowering operational costs and risks. Its customer base includes leading organizations such as Anglian Water, ArcelorMittal, and Nobian, reflecting its significant impact on the industrial sector.

Median Technologies SA is a company that specializes in developing and marketing software products for medical image analysis, primarily focused on oncology. Founded in 2002 and based in Valbonne, France, the company offers two main platforms: iBiopsy, which utilizes AI for biomarker identification and patient profiling through CT scans, and iSee, designed for image analysis and management in clinical trials. Median Technologies aims to enhance the diagnosis of cancer patients and assess their treatment responses by standardizing and automating medical image interpretation. The company operates in two main markets: drug development and patient care, and collaborates with a contract research organization to provide integrated imaging services for clinical trials. Additionally, it has partnered with Canon to innovate new imaging technologies for the patient care sector.

NXP Semiconductors N.V. is a prominent supplier of high-performance mixed-signal semiconductor products, headquartered in Eindhoven, the Netherlands. Founded in 2006, the company offers a diverse product portfolio that includes microcontrollers, application processors, communication processors, and various wireless connectivity solutions such as Bluetooth, Wi-Fi, and Near Field Communications. NXP's technology is integral to multiple applications across automotive, industrial, Internet of Things, mobile, and communication infrastructure sectors. The company has established a significant presence in the automotive market, providing essential components for powertrains, infotainment systems, and safety systems. Additionally, NXP maintains operations in over 25 countries and has formed strategic partnerships, including collaboration with Amazon Web Services to enhance connected vehicle solutions.

EDP Renewables is a global renewable energy company focused on creating value, innovation, and sustainability. Operating in markets worldwide, they are expanding their presence to new regions to lead in each market and provide value to stakeholders and shareholders. With a history of developing wind farms since 1996, EDPR manages assets in the European Union through EDPR Europe and in the United States and Canada through EDPR North America. As a majority shareholder, Energias de Portugal, S.A. (EDP) contributes to EDPR's operational excellence. EDP Group, Portugal's largest industrial group, is a key player in the Iberian Peninsula's energy sector, with interests in electricity and gas generation, distribution, and supply in Portugal, Spain, and Brazil. By focusing on high-quality assets and attractive markets with growth prospects and stable regulatory structures, EDPR aims to generate profits and maintain its position as a leader in the renewable energy industry.

Energias de Portugal (EDP) is a prominent global energy company based in Lisbon, Portugal, founded in 1976. It operates primarily in the electricity and gas sectors, offering services in generation, distribution, and trading. EDP is one of the largest energy operators in the Iberian Peninsula and ranks as the third-largest producer of wind energy in the region. The company emphasizes value creation, innovation, and sustainability, reflecting its commitment to customers, society, and the environment. EDP's diverse workforce spans multiple continents, fostering a culture that respects the various markets in which it operates. Additionally, EDP is recognized for its performance in transparency and sustainability, as evidenced by its inclusion in the Dow Jones Sustainability Indexes.

Emerging Markets Global Advisory is an investment bank based in London, United Kingdom, specializing in providing advisory services to financial institutions, institutional investors, and large-cap and middle-market corporations across various industries. The firm offers a comprehensive suite of investment banking services, including mergers and acquisition advisory, corporate finance, debt and equity capital raising, leveraged buyouts, restructurings, valuation analysis, recapitalizations, and divestitures. Emerging Markets Global Advisory serves clients in sectors such as financial services, manufacturing, transportation, agriculture, food, energy, and communications, helping them navigate complex financial landscapes and achieve their strategic objectives.

Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.

Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.

Enpal GmbH is a Berlin-based company founded in 2017 that specializes in providing comprehensive renewable energy solutions, primarily through the installation and operation of solar panels for residential electricity generation. The company offers a range of products, including solar panels, batteries, wallboxes, heat pumps, and energy management systems, catering to customers in Germany and Italy. Enpal initially adopted a sales-based model but successfully transitioned to a lease model that requires no upfront payment and includes installation, insurance, and maintenance services. This approach has resulted in significant growth, with over 60,000 solar PV systems installed and revenues exceeding 400 million euros as of 2022. Enpal employs more than 1,000 team members, including over 200 local installer teams, and has opened several satellite offices to enhance customer service across its markets. The company has received numerous awards for its contributions to sustainability and customer service, positioning itself as a leader in the solar PV installation sector in Germany.

Polski Koncern Naftowy Orlen is a prominent energy conglomerate operating primarily in the oil and gas sector. The company refines and distributes oil in Poland, the Czech Republic, Germany, and Lithuania, processing crude oil into various products such as gasoline, diesel, fuel oil, and aviation fuel through its network of refineries. In addition to refining, Orlen produces petrochemicals and chemical feedstock. The company is also involved in exploration and production activities in Poland and Canada. Orlen's extensive logistics infrastructure supports its operations, featuring both surface and underground storage depots, as well as a long-distance pipeline network, which facilitates the distribution of oil products through a widespread network of service stations.

GEWOBA Aktiengesellschaft Wohnen und Bauen is a prominent real estate company based in Bremen, Germany, founded in 1924. The company specializes in residential real estate management, acquisition, construction, urban development, leasing, and brokerage services. In addition to its real estate operations, GEWOBA also oversees the Gewoba Foundation, established in 1999, which focuses on providing commercial and residential rental properties, along with property management and development services. The foundation's assets are managed by a dedicated board of directors, ensuring effective governance and operational oversight.

Vay is a Berlin-based deep technology company that is on track to launch the first driverless, safety-certified, commercial fleet on European public streets. The company aims to revolutionize urban transportation by enabling remote-controlled cars, offering a safer, more efficient solution for ride-hailing and vehicle-sharing services. Vay’s unique approach blends the advantages of self-driving technology with human supervision to ensure safety and adaptability in complex driving environments. Their goal is to reduce urban congestion, cut emissions, and make mobility more sustainable while providing a seamless transportation experience for users.

NVision Imaging Technologies GmbH, founded in 2015 and based in Ulm, Germany, specializes in developing and commercializing innovative imaging and sensing applications grounded in quantum physics. The company has created a platform that polarizes natural metabolites, enabling their use as agents for imaging tumor metabolism through magnetic resonance imaging (MRI). This technology leverages advancements in quantum physics to transform the medical imaging and diagnostics landscape, allowing standard Magnetic Resonance Spectrometers to evaluate human metabolism. As a result, healthcare professionals can conduct advanced cancer diagnostics and monitor treatment responses in real-time, enhancing the precision and effectiveness of cancer care.

Fab’entech, founded in 2009 in Lyon, France, is a biopharmaceutical company that specializes in developing and commercializing innovative passive immunotherapeutic solutions. The company focuses on specific polyclonal immunoglobulins [F(ab’)₂], targeting emerging infectious diseases and certain drug intoxications. By utilizing highly purified fragments of horse-specific polyclonal immunoglobulins, Fab’entech aims to provide healthcare institutions with effective treatments for urgent medical situations. As a member of the LyonBiopôle cluster, the company is positioned within a vibrant network dedicated to advancing biopharmaceutical innovation.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks aimed at rural and suburban areas. As a pioneering provider in the industry, the company focuses on delivering fiber-to-the-home (FTTH) connections to private households, businesses, and public institutions. By collaborating closely with municipalities, Deutsche Glasfaser aims to facilitate nationwide broadband expansion, contributing significantly to Germany's digital progress. The company is recognized for its innovative and cost-efficient approaches to fiber optic deployment, positioning itself as a technology leader in the market. With substantial backing from experienced investors, Deutsche Glasfaser has emerged as one of the strongest providers in Germany's telecommunications landscape.

Stark Future, founded in 2019 by Anton Wass and Paul Soucy, is a Spanish company with Swedish origins, dedicated to revolutionizing the motorcycle industry through sustainable technologies. Located near Barcelona, the company aims to reduce emissions and pollution by producing high-performance electric motorcycles using eco-friendly materials. The Stark VARG, launched in December 2021, exemplifies this mission; it features an 80-horsepower, near-silent engine and advanced technologies such as a smartphone dashboard and a bike setup app. The development of the VARG involved eight patented innovations and garnered significant attention, achieving €9 million in advance sales within the first 24 hours and generating €50 million in its first month. Within two months of its launch, Stark Future sold over 5,000 motorcycles, positioning itself as a leader in the sustainable mobility sector. The company is also noted for its team, which includes former motocross world champion Sebastien Tortelli as test manager, further emphasizing its commitment to performance and innovation.

Protembis GmbH, established in 2017 and based in Aachen, Germany, specializes in the development of innovative surgical equipment, particularly focusing on minimally invasive medical devices. The company's flagship product, the ProtEmbo System, is an intra-aortic filter designed to mitigate the risk of cerebrovascular events during transcatheter aortic valve replacement (TAVR) procedures. This device effectively deflects embolic material generated during these cardiovascular interventions away from the cerebral circulation, thereby reducing the likelihood of brain injury. By enhancing the safety of TAVR, Protembis aims to improve patient outcomes, particularly as this procedure becomes more common among younger and lower-risk individuals. Through its advancements, Protembis is committed to increasing the quality of life for patients while also addressing the broader healthcare costs associated with complications arising from surgical interventions.

Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Nyxoah's primary product, the Genio system, is a CE-Mark validated bilateral neurostimulation therapy designed to address OSA, which is recognized as the most prevalent sleep disordered breathing condition. OSA is linked to various health risks, including increased mortality and comorbidities such as cardiovascular diseases, depression, and stroke. The Genio system emphasizes user-centered design and represents a next-generation approach to treating this critical health issue.

XOCEAN Limited is a company that specializes in providing Data Collection-as-a-Service through its innovative uncrewed surface vessels (USVs). Founded in 2017 and based in Greenore, Ireland, XOCEAN focuses on delivering comprehensive ocean data solutions for surveyors, government bodies, and various offshore industries. The company's USVs are designed for unmanned operations over the horizon, utilizing satellite communications for real-time data acquisition, processing, and interpretation. XOCEAN also offers its CyberDeck, a secure cloud-based platform that enables remote monitoring and control of USVs, ensuring high-quality data collection while allowing adjustments to sensor parameters as needed. Their services encompass a range of applications, including seabed mapping, environmental monitoring, fisheries, bathymetry, and met ocean data. By leveraging proprietary technology, XOCEAN provides a safe, economical, and carbon-neutral approach to meeting the ocean data needs of its clients.

Intrinsic ID B.V. is a digital authentication company specializing in security solutions for the Internet of Things (IoT) and embedded applications. Founded in 2008 and based in Eindhoven, the Netherlands, with operations in Korea, the company has developed the SRAM Physical Unclonable Function (SRAM PUF) technology that utilizes manufacturing variations in semiconductors to generate unique IDs and cryptographic keys. Its product offerings include Broadkey, Citadel, Quiddicard, and Quiddikey, which facilitate secure key management, key provisioning, and anti-counterfeiting measures. Intrinsic ID's solutions are employed to enhance the security of payment systems, ensure secure connectivity, authenticate sensors, and protect sensitive military and government data.

Evonik Industries AG, headquartered in Germany, is a global specialty chemicals company. It operates in four major segments: specialty additives, smart materials, nutrition and care, and performance materials. Evonik produces and markets chemicals used in diverse industries, from automotive to pharmaceuticals, offering innovative solutions in areas such as animal nutrition, additives, smart materials, health care, and high-performance polymers. The company is a market leader in approximately 80% of its businesses and has a significant presence in Europe, North America, and Asia. Evonik Venture Capital, its corporate venture arm, invests in startups and venture capital funds with innovative technologies and high growth potential, focusing on areas such as resource efficiency, specialty additives, health & care, and nutrition.

ABN AMRO Bank N.V., established in 1720, is a prominent Dutch bank offering a comprehensive range of financial services to retail, private, and corporate clients both domestically and internationally. It operates through four primary segments: Retail Banking, Commercial Banking, Private Banking, and Corporate & Institutional Banking. The bank provides services such as savings accounts, credit cards, loans, mortgages, and wealth management, along with asset-based solutions, working capital solutions, and trade finance. ABN AMRO is committed to sustainability, with a dedicated fund investing in companies and projects contributing to the energy, circular, and social impact transitions. The bank is headquartered in Amsterdam, the Netherlands, and is one of the country's largest banks, serving clients through a network of branches, contact centers, and digital platforms.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

Volvo Car Group, established in 1927, is a global premium car manufacturer headquartered in Gothenburg, Sweden. It produces a range of vehicles including sedans, estates, cross country vehicles, SUVs, and convertibles, renowned for their intuitive Scandinavian design and focus on safety and sustainability. With sales in over 100 countries, Volvo Cars' largest markets are the United States, Sweden, China, Germany, and the UK. The company is committed to sustainable mobility, offering plug-in hybrid and electric cars, and is owned by Zhejiang Geely Holding of China. Volvo Car USA, based in Mahwah, New Jersey, is responsible for the production and sales of Volvo cars in the United States.

Zealand Pharma A/S is a biotechnology company based in Copenhagen, Denmark, specializing in the discovery and development of peptide-based medicines. The company has a growing proprietary pipeline that includes several clinical candidates such as glepaglutide for short bowel syndrome and dasiglucagon for diabetes management and congenital hyperinsulinism. Zealand's first developed medicine, lixisenatide, is a once-daily GLP-1 analogue for Type 2 diabetes, marketed globally outside the US. The company has established collaborations with major pharmaceutical partners, including Sanofi, Helsinn Healthcare, and Boehringer Ingelheim, enhancing its product offerings and expanding its reach in the market. Zealand Pharma is committed to advancing innovative therapies, with multiple projects in various stages of clinical development and preclinical research.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. It specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. The company has created the world's first graphene-based brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation. This innovative technology allows for real-time monitoring and adaptive, personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. By utilizing AI-driven solutions, INBRAIN maximizes therapeutic outcomes while minimizing side effects. The company is also expanding its capabilities through strategic partnerships, including collaborations with Merck KGaA and its subsidiary INNERVIA Bioelectronics, to explore applications in peripheral nerve and systemic diseases, advancing the field of neurotechnology and bioelectronics.

VoltStorage GmbH is a German company specializing in the development and production of solar energy storage systems. Based in Olching, Germany, it utilizes eco-friendly vanadium redox flow technology to create power storage devices that allow homeowners to store surplus solar energy generated during the day for use at night. This innovative approach aims to provide renewable energy availability around the clock, contributing to a cleaner and fairer world for future generations. VoltStorage also offers installation and technical support services for its products, which are sold online. The company's commitment to sustainability underscores its mission to enhance the accessibility of renewable energy.

Repsol is a Spanish integrated energy company that specializes in oil and gas production, as well as renewable energy solutions. With a daily production of 599,000 barrels of oil equivalent and proven reserves totaling 1.8 billion barrels, Repsol maintains a significant presence in the global energy market. The company operates a downstream segment with a refining capacity of 1 million barrels per day, complementing its upstream activities. Repsol is also focused on innovation and sustainable energy, having developed a renewable power generation capacity of 2.8 gigawatts. With operations in key energy regions such as Brazil, Russia, and the United States, Repsol is dedicated to creating a new energy model that encompasses both traditional and renewable energy sources.

Endesa is an electric utility company headquartered in Madrid, Spain, that generates, distributes, and supplies electricity primarily in Spain and Portugal. Founded in 1944, the company has an installed generation capacity of 22 gigawatts, utilizing a diverse mix of energy sources, including hydroelectric, nuclear, coal, natural gas, oil, solar, and wind. Endesa serves approximately 11.2 million customers and employs over 10,000 people. In addition to its core electricity services, Endesa operates in the natural gas sector and provides energy-related services, emphasizing a commitment to sustainability and technological innovation to address current and future energy challenges. The company also supplies gas to retail and business customers in Spain and France.

University College Cork is a prominent higher education institution located in Cork, Ireland, established in 1845. The university offers a diverse range of academic programs, including subjects such as Accounting and Zoology, catering to a wide array of student interests and career aspirations. Nestled on a picturesque limestone bluff, the campus provides an inspiring environment conducive to learning and research. As a pivotal player in the Irish education landscape, University College Cork aims to facilitate the advancement of higher education in Ireland, adapting to the evolving needs of students and society.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Trucksters is a Madrid-based freight startup that specializes in long-haul transport services through an innovative relay system. This approach utilizes big data and artificial intelligence to optimize logistics, significantly reducing transit times for long-distance road freight. By enabling trucks to remain continuously in motion via strategically placed relays, Trucksters enhances delivery efficiency and lowers transportation costs. The company serves over 500 shippers across the European Union, contributing to the acceleration of the electrification agenda while also aiming to improve the quality of life for drivers.

Wingcopter GmbH is a German manufacturer of advanced delivery drones, specializing in unmanned aircraft systems designed for both social and civilian applications. Founded in 2014 and based in Darmstadt, the company focuses on optimizing medical supply chains and last-mile logistics for various sectors, including healthcare, agriculture, forestry, and mining. Its flagship model, the Wingcopter 198, features a patented tilt-rotor mechanism that allows for vertical takeoff and landing while enabling efficient long-distance flight, even under challenging weather conditions. The drones are utilized for delivering essential items such as medicines, vaccines, and food to remote locations, as well as for inspecting public infrastructure. Wingcopter's commitment to improving and saving lives has garnered recognition, including being named a Technology Pioneer by the World Economic Forum in 2020. The company employs a dedicated team of 120 professionals focused on meaningful commercial and humanitarian applications.

AT&S is a European manufacturer of printed circuit boards, specializing in high-end technology. The company provides a diverse array of printed circuit boards tailored to meet specific customer requirements, including double-sided plated-through, multi-layer, high-density interconnection, laser-drilled insulated metallic substrates, flexible, rigid-flex, and semi-flexible options. AT&S serves various core markets, such as mobile devices, automotive, industrial, medical, aviation, and advanced packaging. With a workforce of approximately 7,300 employees, including around 1,200 in Austria, AT&S is headquartered in Leoben, Austria. The company has demonstrated notable financial performance, achieving significant sales revenues in recent years.

Smart Reporting GmbH is a Munich-based company that specializes in providing a digital health solution for structured medical reporting, particularly in the fields of radiology and pathology. Established in 2014, the company offers an online platform that enables radiologists to generate high-quality medical reports through intelligent software that adheres to guideline-compliant criteria. The platform facilitates the creation of report templates, automatic text suggestions, and integration with hospital systems, thereby enhancing the efficiency and quality of medical reporting. Additionally, Smart Reporting provides tools for hospitals and practices to implement reporting standards, optimize templates, and ensure consistent report appearance across various physicians. The company also supports medical registries and clinical studies with solutions for structured reporting, data collection, and multilingual capabilities, all aimed at improving communication and quality assurance in medical documentation.

SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

GeNeuro is a clinical-stage biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to the expression of pathogenic proteins derived from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody aimed at treating multiple sclerosis, while temelimab, another candidate, neutralizes a pathogenic protein associated with the HERV-W family. In addition to its therapeutic developments, GeNeuro also focuses on creating diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, GeNeuro is committed to addressing the underlying causes of neurodegenerative and autoimmune diseases.

Reden Solar is a company focused on the development, financing, construction, and operation of solar photovoltaic power plants across Europe and Latin America. With an installed portfolio of 762 megawatts and an additional 15 gigawatts under development, the company primarily operates in France and Spain while recently expanding into Greece and Italy. Reden Solar offers a diverse range of photovoltaic solutions, including agricultural greenhouses, ground-mounted plants, photovoltaic shelters, and rooftop installations. By providing these innovative energy solutions, Reden Solar aims to promote sustainable development and contribute to a cleaner planet through renewable energy production.

Orange is a global telecommunications company, founded in 1991 and headquartered in Paris, France. It operates in 30 countries across Europe and Africa, providing mobile and internet services to consumers, and corporate telecommunication services worldwide. Through its business arm, Orange Business Services, it caters to large corporates, local authorities, and SMEs, offering a comprehensive range of voice and data, IT, and integrated services. Additionally, Orange supports digital innovation through its international network of startup accelerators, Orange Fabs, which provides resources and expertise to startups in the digital space.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

AB Science, established in 2001 by a team of researchers, clinicians, and entrepreneurs, is a France-based pharmaceutical company focused on developing innovative treatments for significant unmet medical needs. The company specializes in the research, discovery, development, and marketing of protein kinase inhibitors, particularly tyrosine kinase inhibitors. These targeted therapies aim to treat various diseases, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases, with applications in both human and veterinary medicine.

Power Capital Renewable Energy Limited, established in 2011 and headquartered in Dublin, Ireland, specializes in developing, operating, and managing large-scale photovoltaic solar farms. The company focuses on acquiring and asset managing utility-scale solar parks, aiming to deliver clean, reliable green electricity. Their expertise spans the entire lifecycle of an asset, from design and development through financing, construction, and operation, ensuring each plant becomes a sustainable and competitive source of renewable energy.

ExeVir Bio BV is a Belgian biotechnology company founded in 2020 and headquartered in Zwijnaarde. The company specializes in developing single-domain antibody-based therapies aimed at preventing viral infections. Utilizing a llama-derived antibody technology platform, ExeVir Bio focuses on creating robust antiviral treatments, particularly targeting coronaviruses. One of its key products, VHH72-FC, binds to a conserved region of the SARS-CoV-2 spike protein, which is crucial for the virus's entry into human cells. The company has established a rapid response platform for antivirals, allowing for a quick adaptation to emerging health threats through a streamlined process for generating drug candidates. Their protein-based therapeutics are designed to be stable, cost-effective, and accessible on a global scale, addressing significant public health challenges posed by viral infections.

Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.

AB Science, established in 2001 by a team of researchers, clinicians, and entrepreneurs, is a France-based pharmaceutical company focused on developing innovative treatments for significant unmet medical needs. The company specializes in the research, discovery, development, and marketing of protein kinase inhibitors, particularly tyrosine kinase inhibitors. These targeted therapies aim to treat various diseases, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases, with applications in both human and veterinary medicine.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

LeydenJar Technologies B.V., founded in 2016 and based in Leiden, the Netherlands, focuses on enhancing the energy density of lithium-ion batteries through the innovation of pure silicon anodes. By replacing traditional graphite anodes with a nanoporous silicon alternative, the company significantly increases the energy density of batteries by up to 70%, achieving a performance level of 1350Wh/L. This advancement not only improves battery efficiency but also reduces costs by approximately 20% and minimizes the carbon footprint by 85%, contributing to greener energy solutions.

Advicenne is a late-stage biopharmaceutical company established in 2007 and headquartered in Nîmes, France. It focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly for orphan renal diseases and niche neurology indications. The company's lead drug candidate, ADV7103, is currently undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the quality of life for patients from early childhood through adulthood.

OVH APAC is a leading cloud provider known for its innovative and cost-effective solutions tailored for a diverse clientele, ranging from startups to large enterprises. Founded in 1999 by Octave Klaba and based in France, OVH offers a comprehensive portfolio of services, including web hosting, dedicated servers, cloud solutions, domain registration, and VOIP telephony. The company distinguishes itself through its proprietary global fiber-optic network and green data centers, which enable optimal performance and reliability. With a commitment to research and development and complete control over its supply chain, OVH delivers high-quality products and exceptional customer service. Additionally, OVH has established a strong partnership with VMware, integrating advanced software solutions to enhance network performance and streamline service delivery for its customers. As a result, OVH is recognized as one of the top internet hosting companies globally, serving millions of customers with cutting-edge technology and expertise.

GomSpace is a Danish space company founded in 2007 that specializes in the development and commercialization of nano-satellites. It offers turn-key solutions for various applications, including Internet of Things (IoT), communication, tracking, surveillance, and remote sensing. GomSpace provides a range of products such as professional nano-satellite solutions, commercial off-the-shelf sub-systems, software modules, and customizable payloads designed to meet specific customer requirements. The company operates across diverse sectors, including academia, commercial enterprises, defense, and scientific research, with a global presence that extends to Europe, the United States, Asia, and beyond. Through its innovative approach to nanosatellite technology, GomSpace aims to facilitate the growth of space-based businesses and services.

Energiefonds Overijssel is a venture capital firm established in 2012 and located in Zwolle, Netherlands. The company is dedicated to supporting the energy transition by providing financial contributions to initiatives and businesses that focus on energy savings or the generation of energy from renewable sources. Backed by the government, Energiefonds Overijssel prioritizes investments in renewable energy and clean energy technology, aiming to foster sustainable practices and innovation within the energy sector.

GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on the discovery and development of gene therapies for retinal degenerative diseases and neurodegenerative disorders of the central nervous system. Founded in 2012, the company utilizes innovative technologies, including mitochondrial targeting sequences and optogenetics, to develop treatments that aim to preserve or restore vision in patients with severe vision impairments. Its lead product candidates include GS010, an AAV2-based gene therapy that is currently undergoing Phase III clinical trials for Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is in Phase I/II trials for retinitis pigmentosa and geographic atrophy associated with dry age-related macular degeneration. GenSight Biologics is also advancing other product candidates in preclinical development targeting various ophthalmic and neurodegenerative conditions.

Siltronic AG specializes in the development, production, and marketing of semiconductor wafers, a critical component in the electronics industry. Established in 1968 and headquartered in Munich, Germany, the company operates a global network of advanced production facilities in Asia, Europe, and the United States, including state-of-the-art plants for 200 mm and 300 mm wafers in Singapore. Siltronic's product offerings include polished wafers, epitaxial wafers, annealed wafers, floatzone wafers, power products, and ultimate silicon. With a workforce of approximately 3,600 employees, the company serves various geographic markets, including Germany, the broader European region, the United States, Taiwan, mainland China, South Korea, and other parts of Asia.

SpinDiag GmbH is a German company specializing in the development of automated point-of-care systems for the rapid detection of infectious diseases. Founded in 2016 and headquartered in Freiburg, SpinDiag manufactures a compact, user-friendly centrifugal-microfluidic test system that enables healthcare professionals to detect drug-resistant bacteria and other pathogens directly from patient samples. Its flagship product, which includes an automated SARS-CoV-2 test, allows for the screening of up to 25 antibiotic resistances upon patient admission, effectively preventing the spread of infections by isolating affected individuals. The system streamlines the testing process with a fully automated workflow that can be operated by nursing staff, providing laboratory-grade PCR results from standard swab samples without the need for additional sample collection. By integrating this technology into everyday clinical practice, SpinDiag enhances diagnostic efficiency and safety in healthcare settings.

MithraSol specialises in the identification, development, construction and operation of Spanish solar photovoltaic assets and currently has 50MW of assets in development across twelve projects spanning central and southern Spain.

Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Opdenergy is a renewable energy company with over 15 years of expertise, specializing in solar photovoltaic and onshore wind energy. The company has a diverse portfolio of projects across various renewable technologies. Opdenergy operates in Chile, Italy, Mexico, the USA, and Spain, with the majority of its revenue generated from Spain.

Blickfeld GmbH, established in 2016 and based in Munich, Germany, specializes in the production of LiDAR sensors and associated software. These sensors use near-infrared light to detect and map objects, enabling autonomous vehicles to perceive their surroundings. The company's patented silicon MEMS mirrors and commercial off-the-shelf components allow for low-cost mass production, making LiDAR technology more accessible to the automotive industry. Additionally, Blickfeld's object detection and mapping software processes sensor data, facilitating applications such as city planning, real-time mapping, and usage pattern analysis. The company serves various sectors, including automotive, transportation, industrial, and robotics.

Loci Orthopaedics Limited, established in 2017 and headquartered in Upper Newcastle, Ireland, specialises in the manufacture of medical instruments, notably the InDx implant. This innovative device is designed to mimic natural thumb joint motions and offers a less invasive surgical solution for patients with arthritis in their thumb base joint, addressing a significant unmet clinical need in orthopaedics.

Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

Cabify, established in 2011 and based in Madrid, Spain, is a ride-sharing company that facilitates transportation for both individuals and businesses. It offers a user-friendly web and mobile app for booking rides, connecting users with suitable transport options. Cabify prioritizes customer satisfaction, ensuring fair pricing, comfortable journeys, and accessibility for all. Its services include clean, modern vehicles driven by trained professionals, providing safe and reliable rides with added amenities like music and magazines. The company aims to enhance urban mobility and improve cities and communities by making transportation better.

Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

InstaFreight GmbH, founded in 2016 and based in Berlin, Germany, specializes in online freight forwarding services for B2B customers. The company aims to simplify the booking and processing of freight transport, making it fast and straightforward. By focusing on reliability, quality, efficiency, and transparency, InstaFreight seeks to position itself as Europe's leading digital forwarding company. It offers innovative solutions that enhance supply chain management and provide clear visibility for both customers and carriers, ultimately reducing complexity in logistics operations.

Priothera Ltd is a clinical-stage biotechnology company based in Dublin, Ireland, with an additional location in Saint Louis, France. Founded in 2020, Priothera specializes in the development of orally administered sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. The company's leading candidate, mocravimod, is designed to reduce the egress of T cell subsets from lymphatic tissue, thereby enhancing the curative potential of allogeneic hematopoietic stem cell transplantation. By providing dual inhibition of graft versus host disease while promoting graft versus leukemia effects, Priothera aims to significantly improve outcomes for patients undergoing such transplants.

TRUMPF, a German high-technology company, is a global leader in manufacturing sheet metal fabrication machinery, industrial lasers, and medical technologies. It offers a wide range of production solutions, including laser cutting, welding, and marking systems, as well as punching and additive production equipment. TRUMPF Venture, established in 2016, is the company's corporate venture capital arm, investing in early-stage startups that operate in areas complementary or adjacent to TRUMPF's core business, such as advanced photonics and smart factories. The venture capital arm seeks innovative technologies and business models, and provides funded startups with access to its extensive network, deep domain expertise, and support for scaling and market entry. TRUMPF, as an independent, family-owned company, focuses on long-term strategies and continuous innovation to drive digital connectivity in manufacturing.

DyeMansion GmbH, established in Munich, Germany in 2013, specializes in post-processing and coloring of 3D-printed laser sintered parts. The company offers high-volume finishing systems that transform raw, 3D-printed parts into high-value consumer and industrial products, such as eyewear, automotive components, and medical devices. DyeMansion works with major 3D printing systems like EOS, HP, and 3D Systems, enabling precision coloring and finish to exact specifications. With over 400 customers, including leading global manufacturers, DyeMansion has become the global leader in additive manufacturing finishing systems for 3D-printed polymer parts.

DPG Media Group is a media company based in Antwerp, Belgium, specializing in the publication of newspapers, journals, and magazines. It provides a diverse array of news coverage, including entertainment, sports, politics, and market-related stories. In addition to its publishing activities, DPG Media offers advertising services to its clients, catering to a wide audience across Belgium. The company's content encompasses social, scientific, economic, and commercial topics, ensuring a comprehensive approach to media and information dissemination.

Starship Technologies, Inc. is a robotics company that specializes in the design and manufacture of self-driving delivery robots intended for local goods transportation. Founded in 2014, the company is headquartered in London, United Kingdom, with a research and development center in Estonia. Its autonomous robots are capable of delivering parcels, groceries, and food within a 30-minute timeframe, operating autonomously 99% of the time. These robots utilize a suite of sensors, including cameras and GPS, to ensure safe and efficient curb-side deliveries from local hubs. Starship Technologies aims to revolutionize the delivery process by providing convenient services that enhance everyday life while promoting environmentally friendly practices and reducing costs associated with local deliveries.

miDiagnostics is a Belgian company focused on creating innovative testing solutions that allow individuals to perform blood analyses independently. The company is developing a novel chip-based technology that enables the rapid detection of various biomarkers from minimal blood samples, such as those obtained from a finger prick. This technology integrates a nanofluidic processor with a compact reader, facilitating the measurement of cells, proteins, nucleic acids, and small molecules. By providing disposable tests that are easy to use and offer built-in connectivity, miDiagnostics aims to enhance diagnostic capabilities for both patients and clinicians, making lab-quality testing accessible anytime and anywhere.

Stilla Technologies SA is a biotechnology company based in Villejuif, France, with an additional location in Beverly, Massachusetts. Founded in 2013, the company specializes in accelerating the development of next-generation genetic tests through its innovative digital PCR (dPCR) solution known as the Naica System. Utilizing advanced microfluidic technologies, Stilla aims to make dPCR accessible as a standard tool across various life sciences sectors, including research, therapeutics, and genomics. The Naica System offers a flexible platform compatible with multiple chemistries and features multiplex capabilities, providing researchers with high-resolution genetic analysis tools that simplify image processing and data exploration.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

University College Dublin (UCD), founded in 1854, is a prominent research-intensive university located in Ireland. It is the largest and most diverse university in the country, with a student population exceeding 30,000 from around 124 nations. UCD provides a broad range of undergraduate and graduate programs, including fields such as accounting and biology. The institution emphasizes an innovative and flexible educational experience through its UCD Horizons curriculum, catering to the intellectual and personal development of students. UCD is particularly recognized for its graduate education, hosting approximately 7,000 graduate students and nearly 2,000 PhD candidates, with over half of its undergraduates continuing to pursue advanced studies. Through its commitment to research, innovation, and community engagement, UCD plays a vital role in fostering academic excellence and development in Ireland.

Ørsted is a Danish company specializing in the development and maintenance of offshore and onshore renewable energy farms, energy storage facilities, and bioenergy plants. Formerly known as DONG Energy, Ørsted has undergone a significant transformation over the past decade, committing to a vision of a world powered entirely by green energy. The company has dramatically reduced its coal consumption by 73% and aims to completely phase out coal by 2023. As a global leader in offshore wind, Ørsted holds a 25% market share, providing energy to approximately 9.5 million people. By the end of 2023, Ørsted operated 8.9 gigawatts of offshore wind capacity, with the United Kingdom being its largest market, followed by Germany and Denmark. The company is also expanding its presence outside Europe with projects in Taiwan and the United States, where it operates 4.8 gigawatts of onshore wind and solar assets. In addition to its renewable initiatives, Ørsted still engages in traditional utilities, including conventional power plants.

OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes, France, specializing in the development of innovative immunotherapies aimed at immune activation and regulation, particularly in the areas of immuno-oncology and autoimmune diseases. The company's product portfolio includes Tedopi, which is in Phase III clinical trials for lung cancer and Phase II for pancreatic cancer; BI 765063, currently in Phase I trials for solid tumors; and OSE-703, a humanized monoclonal antibody in preclinical development for various cancers. Additionally, OSE Immunotherapeutics is advancing FR104, which is in Phase I trials for rheumatoid arthritis, and OSE-127, a humanized monoclonal antibody in Phase I trials for inflammatory autoimmune diseases. The company collaborates with notable partners such as GERCOR, Memorial Sloan Kettering Cancer Center, Boehringer Ingelheim, Servier, and HalioDx. OSE Immunotherapeutics was previously known as OSE Pharma SA before its name change in May 2016.

Bone Therapeutics SA is a biotechnology company based in Gosselies, Belgium, that specializes in the development of innovative cell therapy products for orthopedics and bone diseases. Established in 2006, the company has created a robust product pipeline, including ALLOB, an allogeneic cell therapy currently in Phase II clinical trials aimed at treating delayed-union fractures and spinal fusion procedures. Bone Therapeutics also conducts preclinical research on next-generation products, such as combined cell-matrix therapies for large bone defects and maxillofacial applications. The company collaborates with various partners to develop personalized, tissue-engineered bone implants, leveraging its extensive expertise in bone and joint physiology, along with advanced production methods and minimally invasive treatment techniques.

Red Points is a technology company based in Barcelona, Spain, that specializes in online brand protection. Founded in 2011, the company offers a software-as-a-service platform designed to combat online counterfeiting, digital piracy, and distribution fraud. Utilizing advanced machine learning and computer vision techniques, Red Points' software effectively detects and removes counterfeit goods and pirated content from the internet. The platform operates across more than one hundred online marketplaces and social networks, addressing hundreds of thousands of incidents each month. With a client base that includes over five hundred brands worldwide, such as Bang & Olufsen, MVMT, and DOPE, Red Points provides essential solutions for brands and content owners seeking to safeguard their intellectual property rights in the digital landscape.

Bouygues Telecom is a prominent telecommunications operator in France, offering a wide range of services that include mobile, fixed-line, television, internet, and cloud computing. The company serves approximately 11.1 million mobile customers and 2.1 million fixed broadband customers, including over 1.5 million professional and corporate clients. Renowned for its innovative approach, Bouygues Telecom has introduced several pioneering products, such as the first unlimited call plans, fixed-mobile convergence offers for corporate customers, and the quadruple play solution known as ideo. The company also launched B&YOU, a web-only offer that revolutionized mobile telephony. With a mobile network that covers 99% of the population and a rapidly expanding 4G network, Bouygues Telecom is committed to enhancing customer experience through its dedicated team of over 9,000 employees and a robust customer service framework that includes 2,000 advisers and 2,500 sales staff. The company's focus on innovation and customer satisfaction positions it as a key player in the French telecommunications market.

Area9 Lyceum ApS is a Copenhagen-based company that specializes in developing personalized and adaptive online learning modules for schoolchildren, students, and professionals. Founded in 2017, Area9 Lyceum focuses on providing education through digital platforms, utilizing a cloud AI-based educational approach. The company integrates blended learning techniques, offering a comprehensive platform that includes authoring, review, delivery, and reporting capabilities. This enables clients to personalize training and effectively manage content delivery, thereby reducing development time. Additionally, Area9 Lyceum is part of a broader group that includes Area9 Innovation, which supplies high-technology computer science solutions aimed at optimizing human resources in sectors such as call centers and process optimization for major corporations, including banks and pharmaceutical companies.

IDnow is a Munich-based company that specializes in identity verification technologies through its Identity-as-a-Service platform. Founded in 2014, IDnow employs advanced machine-learning techniques to offer real-time identity verification and electronic signing solutions, ensuring legal security and high data protection standards across Europe. Its services are tailored for business clients, including banks, telecommunications companies, and fintech firms, facilitating online customer identification and contract conclusion without the need for additional hardware. The platform allows users to verify their identities conveniently using smartphones, tablets, or webcams. IDnow's client roster features prominent organizations such as Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26, highlighting its role as a key player in the identity verification sector.

Worldsensing is a leader in Internet of Things (IoT) solutions, specializing in low-power wireless sensing networks that enhance critical infrastructure. The company has developed comprehensive vertical solutions targeting two primary markets: Mobility and Industrial Solutions. In the Mobility sector, Worldsensing offers innovative products like Bitcarrier, a real-time traffic flow management system, and Fastprk, a leading smart parking solution. In the Industrial Solutions market, the LS-G6 platform is used to monitor vital assets in remote locations, including bridges, tunnels, and power lines. Founded in 2010, the company has established its presence in Barcelona and London, employing over 40 professionals. Worldsensing's achievements include multiple awards for its products, such as the Stockholm Smart City Living Labs Global Award for Fastprk and recognition from Gartner for Bitcarrier as a "Cool Vendor." The company is committed to providing clients with real-time insights to improve decision-making in both smart city and industrial contexts.

Spire Global, Inc., established in 2012 and headquartered in San Francisco with offices in Glasgow and Singapore, specializes in satellite data services. The company offers two primary data services: Spire Sense, which provides ship tracking data for applications such as illegal fishing monitoring, trade analysis, and maritime domain awareness; and Spire Stratus, which delivers global weather data. Additionally, Spire Global provides machine learning and analytics tools to enhance vessel detection and information gathering. Its clients include mining companies, government authorities, port operators, and those involved in arctic shipping routes.

Robart is an Austrian high-tech start-up established in 2009, dedicated to developing autonomous mobile robots for both consumer and industrial applications using its proprietary Artificial Intelligence Control Unit (AICU) technology. The company aims to democratize robotics with the vision of integrating robots into everyday life, focusing on creating low-cost solutions that empower industry leaders to innovate in the robotic product space. Robart's robots are designed to enhance user experience by detecting obstacles and navigating complex home environments, offering functionalities such as smart cleaning and mopping. By addressing current limitations in consumer robotics, Robart emphasizes precise task execution, robust functionality, and intuitive user interaction, positioning itself at the forefront of next-generation intelligent robotics.

Magazino GmbH is a Munich-based company that specializes in the development and production of mobile robots tailored for the storage and intralogistics sectors. Founded in 2014, the company focuses on creating perception-controlled robots capable of identifying, grasping, and placing individual items precisely, utilizing advanced 2D and 3D camera technology. Their product offerings include mobile pick-and-place robots designed for e-commerce warehouses, which operate collaboratively in swarms, and are supported by their proprietary operating systems, ACROS and App ARC. These technologies streamline the automation of daily operations for various clients, including mail-order companies, warehousing facilities, production lines, and pharmacies. Magazino aims to revolutionize the logistics industry by creating intelligent robots that enhance operational efficiency and contribute to the future of robotics.

ESB International is an expanding energy company and a prominent engineering and consultancy organization in Europe. It is responsible for managing the non-regulated operations of its parent company, ESB, and engages in a wide range of activities within the energy sector. ESB International specializes in providing engineering design, construction management, and strategic consultancy services to clients both in Ireland and globally, particularly within the power sector. The firm focuses on supporting energy utilities and business developers, leveraging its expertise to address the diverse challenges in the energy industry.

Advicenne is a late-stage biopharmaceutical company established in 2007 and headquartered in Nîmes, France. It focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly for orphan renal diseases and niche neurology indications. The company's lead drug candidate, ADV7103, is currently undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the quality of life for patients from early childhood through adulthood.

NavVis GmbH, established in 2013 and headquartered in Munich, Germany, specializes in indoor spatial intelligence solutions. The company offers the NavVis M6, a mobile mapping system that captures 360° immersive imagery and point clouds for large-scale scanning projects. NavVis IndoorViewer, their digital twin software, combines point clouds with highly detailed 360° images, enabling stakeholders to explore and interact with scanned spaces. Their solutions cater to various industries, including automotive, construction, real estate, and insurance, serving applications such as CAD/BIM modeling, factory planning, and indoor mapping. NavVis' technology bridges the gap between the physical and digital worlds, providing high-quality data with survey-grade accuracy at speed and scale, thereby driving operational efficiencies and informed decision-making.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

CureVac is a clinical-stage biopharmaceutical company based in Germany, established in 2000, that specializes in developing vaccines and therapies utilizing messenger ribonucleic acid (mRNA). The company focuses on both prophylactic and therapeutic applications of mRNA, enabling the human body to produce proteins that combat various diseases. CureVac's innovative pipeline includes mRNA-based cancer immunotherapies, such as CV9104, which is in Phase IIb development for prostate cancer, as well as RNActive vaccines against infectious diseases and RNArt molecular therapies designed to stimulate the production of therapeutic proteins. Additionally, the company has collaborated with GSK to advance second-generation vaccines for seasonal influenza and COVID-19, alongside an avian influenza vaccine, while also exploring mRNA therapies for oncology and other conditions affecting the liver and eyes.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Azimo, established in 2012, is a London-based digital money transfer company that operates globally. It offers a user-friendly mobile app for sending money internationally, either to bank accounts or over 270,000 cash pick-up points worldwide. Azimo's platform is designed to be fast, secure, and cost-effective, providing an alternative to traditional high street remittance services. It supports both Android and iOS devices, enabling users to transfer funds from any internet-connected device.

Telefónica Deutschland is a prominent integrated telecommunications provider based in Munich, Germany, offering a wide range of mobile and fixed services for both private and business customers. The company manages approximately 49.6 million customer lines, with over 45 million in the mobile segment alone. Telefónica Deutschland's offerings include postpaid and prepaid mobile products, mobile data services utilizing GPRS, UMTS, and LTE technologies, as well as DSL fixed network telephony and high-speed internet services. Following its integration of E-Plus, the company is committed to digitalizing its business model while enhancing customer experience. With aspirations to become the preferred partner in the German mobile service market, Telefónica Deutschland aims to simplify and improve its customers' lives, providing them with mobile freedom in an increasingly digital world.

On Robot is a Danish company founded in 2015, specializing in the manufacture of robotic equipment for automation across various industries. Based in Odense, it develops a range of plug-and-produce end-of-arm tools and software solutions designed to enhance the functionality of collaborative robots. The company's product offerings include electric grippers, sensors, and other equipment that seamlessly integrate with robots to improve efficiency in tasks such as packaging, quality testing, material handling, machine tending, assembly, and welding. By focusing on ease of use, cost-effectiveness, and safety, On Robot enables manufacturers to leverage the advantages of collaborative robots, allowing for flexible and customized automation solutions that work alongside human workers.

Median Technologies SA is a company that specializes in developing and marketing software products for medical image analysis, primarily focused on oncology. Founded in 2002 and based in Valbonne, France, the company offers two main platforms: iBiopsy, which utilizes AI for biomarker identification and patient profiling through CT scans, and iSee, designed for image analysis and management in clinical trials. Median Technologies aims to enhance the diagnosis of cancer patients and assess their treatment responses by standardizing and automating medical image interpretation. The company operates in two main markets: drug development and patient care, and collaborates with a contract research organization to provide integrated imaging services for clinical trials. Additionally, it has partnered with Canon to innovate new imaging technologies for the patient care sector.